使用最小绝对收缩和选择算子(LASSO)识别多发性硬化临床与MRI结局的早期预测因素
该研究分析704例多发性硬化患者,测量37个基线预测因素和10年结局,用LASSO筛选临床结局(侵袭性MS、良性MS、继发进展型MS)的共同预测因素,并比较MRI结局。LASSO选出的10个预测因素模型交叉验证AUC与全模型相当,MRI结局更受初始T2病灶体积和脑实质分数影响。
要点
- LASSO筛选出10个临床结局共同预测因素,包括年龄、EDSS、锥体、小脑、感觉及肠道膀胱体征等。
- 简化模型交叉验证AUC与全37因素模型相当:侵袭性MS 0.84 vs 0.81,良性MS 0.75 vs 0.73,SPMS 0.76 vs 0.75。
- 10年MRI结局更受初始T2病灶体积和脑实质分数影响,而非临床因素。
核心结论
- 使用LASSO建模可从有限的可获取临床特征中对多发性硬化进行早期预后判断。
- 这些预测模型一旦整合到网络计算器中,或可用于临床治疗决策。
研究设计与样本
- 研究分析了本中心704例多发性硬化发病时患者,测量37个基线人口学、临床、治疗和MRI预测因素及10年结局。
- 主要目的是识别临床结局(侵袭性MS、良性MS、继发进展型MS)的共同预测因素,并研究MRI结局(T2病灶体积和脑实质分数)。
- 比较全37预测因素模型与LASSO筛选的共同预测因素模型的性能,使用受试者工作特征曲线下面积(AUC)。
主要发现
- 全37预测因素模型对临床结局预测性高:样本内AUC侵袭性MS为0.91,良性MS为0.81,SPMS为0.81。
- LASSO选出10个临床结局共同预测因素:年龄、扩展残疾状态量表、锥体、小脑、感觉及肠道膀胱体征、定时25英尺步行≥6秒、发作恢复差、无感觉发作和至治疗时间。
- 简化模型交叉验证AUC与全模型相当:侵袭性MS 0.84 vs 0.81,良性MS 0.75 vs 0.73,SPMS 0.76 vs 0.75。
- 10年MRI结局更受初始T2病灶体积和脑实质分数影响,而非临床结局因素。
临床怎么用
- 作者认为这些预测模型一旦整合到网络计算器中,或可用于临床治疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to identify predictors in common between different clinical and magnetic resonance imaging (MRI) outcomes in multiple sclerosis (MS) by comparing predictive models. METHODS: We analyzed 704 patients from our center seen at MS onset, measuring 37 baseline demographic, clinical, treatment, and MRI predictors, and 10-year outcomes. Our primary aim was identifying predictors in common among clinical outcomes: aggressive MS, benign MS, and secondary-progressive (SP)MS. We also investigated MRI outcomes: T2 lesion volume (T2LV) and brain parenchymal fraction (BPF). The performance of the full 37-predictor model was compared with a least absolute shrinkage and selection operator (LASSO)-selected model of predictors in common between each outcome by the area under the receiver operating characteristic curves (AUCs). RESULTS: The full 37-predictor model was highly predictive of clinical outcomes: in-sample AUC was 0.91 for aggressive MS, 0.81 for benign MS, and 0.81 for SPMS. After variable selection, 10 LASSO-selected predictors were in common between each clinical outcome: age, Expanded Disability Status Scale, pyramidal, cerebellar, sensory and bowel/bladder signs, timed 25-foot walk ≥6 seconds, poor attack recovery, no sensory attacks, and time-to-treatment. This reduced model had comparable cross-validation AUC as the full 37-predictor model: 0.84 versus 0.81 for aggressive MS, 0.75 versus 0.73 for benign MS, and 0.76 versus 0.75 for SPMS, respectively. In contrast, 10-year MRI outcomes were more strongly influenced by initial T2LV and BPF than clinical outcomes. INTERPRETATION: Early prognostication of MS is possible using LASSO modeling to identify a limited set of accessible clinical features. These predictive models can be clinically usable in treatment decision making once implemented into web-based calculators. ANN NEUROL 2022;92:87-96.
引用
- Bose G, Healy BC, Lokhande HA, et al. Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis. Ann Neurol. 2022. PMID: 35429009. doi:10.1002/ana.26370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。